Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Lung function development after preterm birth in relation to severity of Bronchopulmonary dysplasia

BMC Pulmonary MedicineBMC series – open, inclusive and trusted201717:97

https://doi.org/10.1186/s12890-017-0441-3

Received: 22 December 2016

Accepted: 23 June 2017

Published: 30 June 2017

Abstract

Background

Bronchopulmonary dysplasia (BPD) is a strong risk factor for respiratory morbidity in children born preterm. Our aims were to evaluate lung function in adolescents born preterm with and without a history of BPD, and to assess lung function change over time from school age.

Methods

Fifty-one individuals born in Stockholm, Sweden between gestational ages 24 to 31 weeks (23 neonatally diagnosed with respiratory distress syndrome (RDS) but not BPD, and 28 graded as mild (n = 17), moderate (n = 7) or severe (n = 4) BPD) were examined in adolescence (13–17 years of age) using spirometry, impulse oscillometry (IOS), plethysmography, and ergospirometry. Comparison with lung function data from school age (6–8 years of age) was also performed.

Results

Adolescents with a history of BPD had lower forced expiratory volume in 1 s (FEV1) compared to those without BPD (−0.61 vs.-0.02 z-scores, P < 0.05), with lower FEV1 values significantly associated with BPD severity (P for trend 0.002). Subjects with severe BPD had higher frequency dependence of resistance, R5–20, (P < 0.001 vs. non-BPD subjects) which is an IOS indicator of peripheral airway involvement. Between school age and adolescence, FEV1/FVC z-scores decreased in all groups and particularly in the severe BPD group (from −1.68 z-scores at 6–8 years to −2.74 z-scores at 13–17 years, p < 0.05 compared to the non-BPD group).

Conclusions

Our results of spirometry and IOS measures in the BPD groups compared to the non-BPD group suggest airway obstruction including involvement of peripheral airways. The longitudinal result of a decrease in FEV1/FVC in the group with severe BPD might implicate a route towards chronic airway obstruction in adulthood.

Keywords

Adolescents Bronchopulmonary dysplasia Lung function tests Oscillometry Spirometry Ergospirometry

Background

In the last decades, an increasing number of infants born at gestational ages (GA) less than 32 weeks survives thanks to improved neonatal care including the use of surfactant, antenatal steroids, and more gentle ventilatory support [1].

Due to preterm birth, lung development is interrupted during the canalicular and saccular/early alveolar phases of normal lung maturation, a process that is supposed to take place in utero. Perinatal exposure to inflammation, infection, mechanical ventilation, and hyperoxia may lead to further insult to the immature lung [2, 3]. Respiratory distress syndrome (RDS) is caused by insufficient levels of surfactant in the alveolus and is common in infants born preterm [4]. The definition is based on the presence of respiratory distress, increasing need for supplemental oxygen and typical chest X-ray findings without any evidence of other causes [4, 5].

Some of the infants with RDS at birth will eventually develop Bronchopulmonary dysplasia (BPD). The “old” BPD defined by Northway et al. [6] was characterized by inflammation, airway smooth muscle hypertrophy, emphysema, and parenchymal fibrosis caused by high oxygen concentration and high ventilation pressures. The success of modern neonatal care where more immature infants survive has been accompanied by the development of a new BPD phenotype with an altered disease pathogenesis compared to “old” BPD. The “new” BPD is characterized by even more immature lung tissue affected by reparative processes, impaired alveolarization, and dysmorphic vascular growth [7, 8]. BPD is currently defined by the need for supplemental oxygen at 28 days of age and can be further classified as moderate or severe BPD based on the level of oxygen need at 36 weeks of gestation [9]. Although previous long-term follow-up studies have shown a negative association between BPD and lung function [10, 11], as well as an increased risk of developing chronic airway obstruction later in adulthood [1214], long-term outcome studies are in need of constant update thanks to the rapid advances in neonatal care. Further, few studies have addressed longitudinal changes up to adolescence, or assessed small airway function, in relation to severity of BPD in this group of patients.

We hypothesized that severity of BPD in children born preterm is associated with impairment of several aspects of lung function that persists into adolescence. The primary aim was therefore to extensively evaluate the influence of BPD severity on exercise capacity and lung function assessed by static and dynamic spirometry, and impulse oscillometry, in a cohort of adolescents born preterm. In addition, we aimed to assess change of lung function from 7 to 14 years of age in relation to BPD severity.

Methods

Participants

The study group consisted of 51 out of 60 children born before 32 weeks of GA as previously described in detail [15]. All children had been treated at the Neonatal Unit of Sachs’ Children’s Hospital, Stockholm, Sweden, between 1992 and 1997. Twenty-eight had been diagnosed with BPD and the remaining 23 with RDS, but not BPD (non-BPD).

The diagnosis of BPD was based on the need for supplementary oxygen at 28 days of age. The severity of BPD was determined at 36 weeks GA as follows: 1) mild BPD - breathing air; 2) moderate BPD - need for supplemental oxygen <30%; 3) severe BPD 30% supplemental oxygen and/or continuous positive airway pressure (CPAP) or ventilator [9].

Perinatal and neonatal data were obtained from medical records and included treatment with prenatal and postnatal steroids, GA at birth, birth weight (BW), instillation of surfactant, number of days on ventilator, CPAP, supplemental oxygen, retinopathy of prematurity (ROP), persistent ductus arteriosus (PDA), necrotizing enterocolitis (NEC), and septicemia. Information on parental smoking was retrieved from questionnaires answered by the parents when the children were approximately 7 years old [15].

Spirometry

At mean age14.5 years (range 13.2–17.0), hereafter referred to as adolescence, lung function in terms of dynamic spirometry and static lung volumes was measured according to American Thoracic Society criteria, using the Sensormedics 6200 body plethysmograph (SensorMedics; Yorba Linda, CA, USA) [16]. Examination was performed with the subject in sitting position and wearing a nose clip. Each subject performed at least three acceptable slow and forced vital capacity expirations. The highest values of forced vital capacity (FVC), and forced expiratory flow in 1 s (FEV1), in addition to mean values of total lung capacity (TLC), functional residual capacity (FRC) and residual volume (RV) were registered. Spirometry at 6–8 years of age has been previously described [15].

Impulse oscillometry (IOS)

The data retrieved from the IOS measurements is thought to represent complex functions of the lung such as small airway obstruction and airway mechanics, including the elastic properties of the lung [17, 18]. Testing was performed using the Jaeger MasterScreen-IOS system (Carefusion Technologies, San Diego, CA, USA). The method has been described in detail elsewhere [19, 20]. In short, pressure impulses were sent from a loudspeaker through the respiratory system. The subjects were encouraged to breathe tidal breathing with the lips tightly sealed around the mouthpiece and supporting cheeks with their hands to avoid impulse pressure loss due to upper airway shunt. After quality inspection, the mean value of resistance at 5 and 20 Hz (R5, R20), frequency dependence of resistance (R5–20) and the area of reactance (AX) were used for analysis [2023]. IOS testing at 6–8 years of age has been previously described [15].

Ergospirometry

Maximal exercise capacity was measured using an incremental Monark cycle ergometer (Electronic Ergomedic 839E, Monark Exercise AB, Vansbro, Sweden). Subjects used a mouthpiece and wore a nose clip. Heart rate was monitored continuously. Minute ventilation, oxygen output (VO2) and carbon dioxide output were measured and calculated from a mixing chamber every 30 s using a SensorMedics Vmax Encore (SensorMedics, Yorba Linda, CA, USA). Subjects were instructed to begin pedaling at 60–70 revolutions/min. After 3 min of unloading cycling, load was increased every minute by 15 W. The participants were encouraged to cycle as long as possible. Peak values for all variables were obtained by averaging data over the last 20 s of maximum completed work. Peak VO2 in ml/kg/min was predicted using formulae for healthy subjects [2426].

Statistical analysis

Demographic data are presented as median and range for continuous variables, or numbers and percentages for categorical variables. Due to non-normally distributed data, comparisons between groups were performed using the Wilcoxon rank-sum test for continuous variables. The Pearson’s χ-squared test was used for categorical outcomes.

FVC, FEV1 and FEV1/FVC were converted to z-scores using the Global Lung Initiative reference values (GLI) [27]. Cross-sectional and longitudinal comparisons between groups were made using the Wilcoxon rank-sum test. Trends across BPD severity groups were assessed using the nonparametric test developed by Cuzick for trend across ordered group [28].

Associations between other lung function outcomes and BPD severity groups were analyzed using linear regression on the median [17, 2931], adjusting for sex, height, and age when appropriate.

The influence of gestational age, treatment with prenatal and postnatal steroids, surfactant, ROP, PDA, necrotizing enterocolitis, septicemia and maternal smoking on the relationship between BPD and lung function outcomes was evaluated with linear regression on the median.

For longitudinal analysis of impulse oscillometry data mixed models was used. Time-dependent covariates included in the model were height and age. BPD group and sex were time-invariant covariates. To assess potential variations of the effect of BPD on lung function over time, an interaction term between time and BPD group was included in the model. P-values of <0.05 were considered statistically significant. Analyses were performed with the Stata 13.1 software package (StataCorp LP, College Station, TX, USA).

Results

Patient characteristics

Of the original 60 participants, 51 (85%) were included in the follow-up at adolescence. Twenty-eight had been diagnosed with BPD (mild n = 17; moderate n = 7; severe n = 4) and 23 had a neonatal diagnosis of RDS, but not BPD (non-BPD), Fig. 1. Perinatal data of all the participants are presented in Table 1.
Fig. 1

Schematic description of the patient cohort. Abbreviations: BPD = Bronchopulmonary Dysplasia; IOS = Impulse Oscillometry; m = male; f = female

Table 1

Perinatal characteristics of study participants born preterm, by BPD severity

 

Mild BPD

Moderate BPD

Severe BPD

All BPD

Non-BPD

P-values

n = 17

n = 7

n = 4

n = 28

n = 23

(All vs Non BPD)

Gestational age at birth, weeks

27 (24–30)

28 (25–30)

28 (25–29)

27 (24–30)

30 (28–31)

<0.001

Birth weight, g

995 (654–1520)

1145 (597–1252)

905 (775–1210)

1003 (597–1520)

1425 (845–2094)

0.001

Male sex

12 (71%)

6 (86%)

2 (50%)

21 (75%)

12 (52%)

0.51

Instillation of surfactant

1 (5.9%)

3 (43%)

2 (50%)

6 (21%)

1 (4.3%)

0.24

Ventilation therapy, days

0 (0–34)

4 (0–38)

23 (0–33)

1 (0–38)

0 (0–5)

0.003

CPAP, days

31 (4–70)

32 (3–55)

38.5 (13–60)

32 (3–70)

4 (0–18)

<0.001

Supplemental O2, days

54 (27–83)

72 (28–96)

141 (105–180)

62 (27–180)

3 (0–26)

<0.001

Maternal smoking during pregnancy

2 (12%)

2 (29%)

4 (100%)

8 (29%)

6 (26%)

0.06

Prenatal corticosteroid therapy

10 (60%)

4 (57%)

2 (50%)

16 (57%)

15 (65%)

0.96

Septicemia

9 (53%)

4 (57%)

3 (75%)

16 (57%)

4 (17%)

0.22

PDA

9 (53%)

5 (71%)

2 (50%)

16 (57%)

7 (30%)

0.36

ROP grade 3–4

5 (29%)

3 (43%)

2 (50%)

10 (36%)

1 (4.3%)

0.007

Abbreviations: BPD Bronchopulmonary dysplasia, CPAP continuous positive airway pressure, PDA patent ductus arteriosus, ROP retinopathy of prematurity

Data are presented as median (range) or numbers (%)

Spirometry

There was a negative trend for FEV1 and FEV1/FVC measured in adolescence associated with BPD severity (P trend 0.002 for FEV1 and 0.001 for FEV1/FVC). Comparing BPD severity groups to the non-BPD group, significantly lower values for FEV1, FVC and FEV1/FVC was seen in the severe BPD group (Table 2). There were no significant differences between groups for TLC or RV (Table 3).
Table 2

Expiratory flows and volumes in z-scores in school children and adolescents with and without history of BPD

 

Mild BPD

Moderate BPD

Severe BPD

All BPD

Non-BPD

P trend

n = 13

n = 7

n = 4

n = 24

n = 20

 

Spirometry at 6–8 years

 FEV1 z-scores

−1.10** (−1.63;-0.12)

−0.63* (−1.38;-0.41)

−2.63** (−3.56;-2.33)

−1.35 *** (−2.11;-0.41)

−0.13 (−0.51;-0.58)

<0.001

 FVC z-scores

−1.09** (−1.50;-0.12)

−0.54 (−0.62;-0.02)

−2.21** (−2.92;-1.50)

−0.82*** (−1.50;0.03)

0.22 (1.18;0.70)

0.001

 FEV1/FVC z-scores

−0.05 (−1.02;0.90)

−0.26 (−2.03;0.05)

−1.90* (−2.34;-1.04)

−0.26 (−1.70;-0.16)

−0.03 (−1.23;0.59)

0.022

Spirometry at13–17 years

 FEV1 z-scores

−0.40 (−1.48;-0.10)

−0.62 (−2.03;0.38)

−2.43** (−2.95;-2.14)

−0.61* (−2.04;0.07)

−0.02 (−0.37;0.55)

0.002

 FVC z-scores

−0.31 (−0.96;0.28)

0.29 (0.00;1.63)

- 0.77* (−1.28;-0.33)

- 0.18 (−0.85;0.28)

0.35 (−0.43;0.66)

0.175

 FEV1/FVC z-scores

−0.18 (−0.94;0.12)

−1.04 (−2.80;-0.22)

−2.95** (−3.20;-2.17)

−0.82* (−2.57;-0.10)

−0.47 (−1.09;0.58)

0.001

Comparing between non-BPD and BPD groups using the Wilcoxon rank-sum test. P * ≤0.05, ** ≤ 0.01, *** ≤0.001. P-values for trend using nonparametric test for trend across ordered groups. Trend test comparing Non-BPD vs mild, moderate, and severe BPD

Data expressed as median (25th and 75th centiles)

Table 3

Difference in adjusted medians of lung function when comparing BPD groups to “no BPD”

 

Mild BPD

Moderate BPD

Severe BPD

All BPD

Non-BPD

P trend

Static spirometrya

n = 15

n = 7

n = 4

n = 26

n = 20

 

 TLC (mL)

−464 (−1151;224)

345 (−460;1150)

18 (−938;974)

−373 (−932;186)

Ref

0.848

 RV (mL)

−148 (−536;240)

−147 (−602;307)

215 (−325;754)

−100 (−360;160)

Ref

0.773

Impulse oscillometrya

n = 16

n = 7

n = 3

n = 26

n = 22

 

 R5–20 (kPa/L/s)

0.036 (−0.019;0.090)

0.013 (−0.069;0.095)

0.340*** (0.218;0.461)

0.041 (−0.010;0.093)

Ref

0.029

 AX (kPa/L)

0.034 (−0.322;0.38)

0.134 (−0.403;0.670)

3.704*** (2.907;4.502)

0.115 (−0.187;0.418)

Ref

0.275

Ergospirometryb

n = 13

n = 7

n = 4

n = 24

n = 17

 

 VO2 (mL/kg/min)

−1.7 (−9.3;5.9)

−2.3 (−11.8;7.2)

−9.1 (−20.5;2.3)

−4.0 (−10.9;2.9)

Ref

0.069

aAnalysis with linear regression on the median adjusting for age, sex and height. bAnalysis with linear regression on the median adjusting for sex. Trend test comparing Non-BPD vs mild, moderate, and severe BPD

Comparing between non-BPD and BPD groups including all BPD using (a) and (b). P * ≤0.05, ** ≤ 0.01, *** ≤0.001

Data presented as difference (95% CI)

Impulse oscillometry (IOS)

Frequency dependence of resistance (R5–20) showed a trend of increasing resistance values with BPD severity (P trend 0,029), Table 3. The adolescents with severe BPD had significantly higher adjusted R5–20 (0.34 kPa/L/s 95% CI 0.22; 0.46, P < 0.001) and higher AX (3.70 kPa/L 95% CI 2.91; 4.50, P < 0.001) compared to non-BPD. The groups with mild and moderate BPD did not differ in comparison with non-BPD.

Ergospirometry

There were no significant differences in VO2 between non-BPD and BPD or within the different groups of BPD (Table 3).

Longitudinal comparison of spirometry and IOS measures between 7 and 14 years of age

FVC and FEV1 z-scores increased over time in all groups (Table 2, Fig. 2). For FVC, the increase was significantly greater for all BPD groups compared to the non-BPD group, with a positive trend with increasing disease severity (P < 0.01 to P < 0.001, P trend <0.001). For FEV1, a significantly larger increase was only observed for the overall BPD (P = 0.02) and mild BPD (P = 0.003) groups, compared with the non-BPD group. In contrast, FEV1/FVC z-scores decreased over time in all groups (with P trend < 0.05 in relation to BPD severity). Comparing between groups, the FEV1/FVC decrease over time was overall larger in all BPD groups compared to the non-BPD group (borderline significant, P = 0.059) and in particular comparing severe BPD and non-BPD (P < 0.05).
Fig. 2

Z-scores presented as median (25th and 75th centiles) for FVC, FEV1 and FEV1/FVC at 7 and 14 years of age in children with no, mild, moderate, severe and all BPD. P-values for comparison of the change from 7 to 14 years in mild, moderate and severe BPD groups compared to the non-BPD group. Nonparametric test for trend across ordered groups comparing mild, moderate and severe BPD to the non-BPD group. P * ≤0.05, ** ≤ 0.01, *** ≤0.001

For IOS, a larger increase of R5–20 values was observed over time in the severe BPD group compared to the non-BPD group (beta +0.011 kPa/L/s 95%CI 0.033; 0.253, P = 0.011), while no differences were seen for the other BPD groups.

Proportion of individuals below the lower limit of normal

In the severe BPD group, 75% (n = 3) of the individuals had a FEV1/FVC z-score below the lower limit of normal (−1.64 z-scores) both at age 7 and in adolescence. Corresponding numbers were 19% (n = 3) at age 7 and 15% (n = 2) in adolescence for mild BPD, and 43% (n = 3) at both ages for moderate BPD.

Discussion

In the current study, we found a trend towards more severe airway obstruction measured by spirometry and IOS with increasing BPD severity. This extends and confirms the findings of both older [11] and more recent [32] cohorts of individuals born preterm. Longitudinal assessment of spirometry suggest a pattern of increasing airway obstruction over time in subjects with a history of BPD. While FVC increased significantly more in all BPD groups compared to the non-BPD group, only marginal increase over time was observed for FEV1. Consequently, a pattern of decreased FEV1/FVC development over time was observed, with a significant trend test in relation to BPD severity and thus the largest decrease in the severe BPD group compared to non-BPD. It should be noted that borderline significant differences in FEV1/FVC development between BPD and non-BPD groups were observed P = 0.059), presumably due to a small size in our study.

Few studies have reported longitudinal data on lung function tested in individuals born preterm, and the results are diverging. Vollsæter et al. [14] reported that trajectories of the lung function indices FEV1 and mid-expiratory flow (FEF25–75) were similar from mid-childhood to adulthood in groups of individuals born preterm and term. However, airway obstruction was observed for preterm subjects during the whole study period and mostly pronounced in the group with BPD. Kotecha et al. [33] suggested tracking of spirometry measurements from 8 to 9 to 14–17 years of age in preterms born in GA 25–32 weeks, while Narang et al. [34] reported an improvement in FEV1, FVC and FEF25–75 when comparing mid-childhood to adulthood data in ex-preterm subjects born in the pre-surfactant era.

In a younger age group of children with moderate to severe BPD, Filippone et al. [35] reported lack of lung function catch-up between early childhood and school-age. Decreasing FEV1/FVC from 8 to 18 years of age in children born preterm with BPD was shown by Fortuna et al. [36] and Doyle et al. [10], and between school age and adolescence in children born moderate to late preterm (at 32–36 GA) by Thunqvist et al. [17]. Nevertheless, the clinical relevance of this observation remains to be evaluated.

Possible explanations of diverse results between studies could be that children are included at different GA, and that the neonatal care has changed regarding treatment with antenatal steroids, surfactant and mechanical ventilation. Another possibility is that there might be differences in how to define the diagnosis of BPD. Many studies use criteria according to Jobe and Bancalari [9] but there have been different strategies how to set saturation limits of what is oxygen dependency that may have influenced BPD diagnosis and severity. Many of the studies, including ours, have a limited number of participants and this might contribute to the diversity because of power issues.

The longitudinal IOS data in the present study showed an increased peripheral airway resistance over time in the group of severe BPD compared to non-BPD. This is in line with the increasing obstructive pattern shown by spirometry. The lack of corresponding response in the reactance parameter Ax could be a reflection of the relative increase in FVC over time seen in the groups with BPD. To our knowledge, there are no other studies reporting IOS measured at more than one time point in individuals born preterm. Malmberg et al. [37] reported higher respiratory resistance and lower reactance measured by forced oscillation technique (FOT) in school age children with BPD. Similar results were demonstrated in pre-school children born preterm with BPD by Vrijlandt et al. [38]. Thunqvist et al. [17] showed an increased frequency dependency of resistance (R5–20) and AX in male subjects born moderate to late preterm measured at 16 years of age. Taken together, ex-preterm subjects seem to have signs of persistent airway obstruction measured by different oscillation techniques, and these observations warrant further studies.

Exercise capacity measured by ergospirometry is not widely described for this group of patients. We did not see any significant differences between the groups of BPD compared to non-BPD even if a tendency towards less work capacity was seen with increasing severity of BPD. In agreement with our study, Vrijlandt et al. [26] showed comparable results using ergospirometry examining exercise capacity in 19–20 years old preterm subjects and term born controls. Other studies have used incremental maximal treadmill exercise test to evaluate exercise capacity after preterm birth and modestly reduced exercise capacity in preterm subjects (but unrelated to BPD severity) has been observed in adolescents [39]. Lovering et al. [25] examined exercise capacity with exercise flow-volume loop protocol and found a reduced inspiratory reserve during near-maximal exercise in adults born preterm with and without BPD compared to term born controls. They also found a more pronounced dyspnea and leg discomfort in the same groups, as well as significantly increased expiratory flow limitation during exercise in subjects with BPD.

The mechanisms underlying long-term respiratory consequences in ex-preterm individuals are being subject to extensive research. Inflammatory processes and disturbed vascularization, partly due to mechanical ventilation and supplemental oxygen, are likely to contribute to irreversible damage of the immature lung parenchyma and the small airways [40]. Animal models have been valuable in providing detailed information about lung development and how different factors may affect the immature lung [41]. For example, the preterm lamb model has proven very useful for studies on pulmonary injury related to different ventilation strategies [42]. Histologically, BPD may lead to simplified and enlarged alveolus, and these anatomical changes are believed to result from an impairment of the postnatal alveolarization process [8]. In post-mortem lung biopsies from infants with a history of BPD, transforming growth factor α (TGF-α) has been found elevated. TGF-α is thought to damage peripheral airway and alveolus development, as well as inhibit pulmonary microvascular development in animal models [43, 44].

Transforming growth factor β1 (TGF-β1) also appears to be important in the development of BPD. In bronchoalveolar lavage-fluid in infants with BPD, Ichiba et al. [45] found elevated levels of TGF-β1 compared to controls. TGF-β1 suppresses alveolar epithelial cell proliferation, resulting in arrest of the alveolarization. This has also been demonstrated in animal models [46]. In other post-mortem materials of preterm infants with severe BPD Bhatt et al. [47] noted abnormal alveolar microvessels and decreased vascular endothelial growth factor (VEGF) expression. Altogether, the more simplified alveolus and disrupted vascular growth reduces the surface area for gas exchange [8].

The strength of the current study is that the individuals are extensively examined with methods covering different aspects of lung function, such as assessment of static and dynamic lung volumes by spirometry, and of smaller airways by impulse oscillometry, at two different time points on average 7 years apart. However, as the number of patients in this study is rather small the results must be interpreted with caution. The study subjects were recruited during a time period (1992 to 1997) when transition to modern neonatal care occurred, and unfortunately, no clear distinction between “old” and “new” BPD cases can be made in our study. Another weakness is the lack of a control group of healthy, full term born individuals. Although the magnitude of lung function impairment could be estimated using the GLI reference values [27], it has been reported that the GLI underestimate FEV1 in Swedish healthy adults and children [17, 48]. Hence, the relative decrease of spirometry measures found in this study might be underestimated. In addition, we did not have access to health records or questionnaire data to assess current respiratory symptoms, own smoking and medication use, or information of parental smoking.

Conclusions

In conclusion, our findings of decreased FEV1 z-scores, FEV1/FVC z-scores and impaired IOS measures in the BPD groups compared to non-BPD suggest a relationship between BPD-severity and increasing airway obstruction, including involvement of the small airways. The decrease in FEV1/FVC and increase of frequency dependence of resistance (R5–20) over time in the group with severe BPD might implicate a route towards chronic airway obstruction in adulthood.

Abbreviations

AX: 

Area of reactance

BPD: 

Bronchopulmonary dysplasia

BW: 

Birth weight

CPAP: 

Continuous positive airway pressure

FEF25–75

Mid-expiratory flow

FEV1

Forced expiratory volume at 1 s

FVC: 

Forced vital capacity

GA: 

Gestational age

GLI: 

Global Lung Initiative

IOS: 

Impulse oscillometry

NEC: 

Necrotizing enterocolitis

PDA: 

Persistant ductius arteriosus

R5–20

Frequency dependency of resistance

ROP: 

Retinopathy of prematurity

RV: 

Residual Volume

TLC: 

Total Lung Capacity

VO2

Oxygen consumption

Declarations

Acknowledgements

The authors would kindly like to thank all the children and their parents who participated in the study.

Funding

Funding Source: The Swedish Heart-Lung Foundation, the Swedish Research Council, the King Oscar II Jubilee Foundation, Swedish Asthma and Allergy Foundation, Karolinska Institutet, Samariten Foundation, Hesselman Foundation and through the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet. The funding sources had no role in planning, conducting or the interpretation of this study.

Availability of data and materials

Anonymized data from the current study is available from the corresponding author on reasonable request.

Authors’ contributions

PUB and JH carried out the hypothesis generation, data acquisition, analysis and manuscript writing together with EM. EBB, PT, MA, GA, CMS participated in the designing and planning of the study. PUB, JH, GF, CMS, GL, EBB, EM, provided statistical support and assistance in the interpretation of the results. All authors drafted, reviewed, and gave final approval to the manuscript as submitted.

Authors’ information

PUB, MD; JH, PhD; PT, MD, PhD; EBB, MD, PhD; MA, MD, PhD; GA, PT; GL, MD, PhD; GF, MD, PhD, Ass. Professor; CMS, MD, PhD, Professor; EM, MD, PhD, Ass. Professor.

Ethics approval and consent to participate

The study was approved by the Regional Ethical Review Board in Stockholm, Sweden, 2007/767–31/2. All parents were fully informed about the purpose and procedures of the study and the parents provided written consent for their child to participate.

Consent for publication

Not applicable.

Competing interests

Petra Um-Bergstrom, Jenny Hallberg, Per Thunqvist, Eva Berggren-Brostrom, Martin Anderson, Gunnar Lilja, Giovanni Ferrara, Carl Magnus Skold, and Erik Melén have stated there is no competing interest in relation to the manuscript.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pediatrics, Södersjukhuset, Sachs’ Children and Youth Hospital
(2)
Lung Allergy Clinic, Karolinska University Hospital
(3)
Department of Medicine Solna, Karolinska Institutet
(4)
Institute of Environmental Medicine, Karolinska Institutet
(5)
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet
(6)
Department of Laboratory Medicine, Clinical Physiology, Karolinska Institutet
(7)
Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University
(8)
Centre for Occupational and Environmental Medicine, Stockholm County Council

References

  1. Field DJ, Dorling JS, Manktelow BN, Draper ES. Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5. BMJ. 2008;336:1221–3.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Balany J, Bhandari V. Understanding the impact of infection, inflammation, and their persistence in the pathogenesis of Bronchopulmonary dysplasia. Front Med. 2015;2:90.View ArticleGoogle Scholar
  3. O'Reilly M, Sozo F, Harding R. Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health. Clin Exp Pharmacol Physiol. 2013;40:765–73.View ArticlePubMedGoogle Scholar
  4. Hjalmarson O. Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study. Acta Paediatr Scand. 1981;70:773–83.View ArticlePubMedGoogle Scholar
  5. Silverman WA, Andersen DH. A controlled clinical trial of effects of water mist on obstructive respiratory signs, death rate and necropsy findings among premature infants. Pediatrics. 1956;17:1–10.PubMedGoogle Scholar
  6. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357–68.View ArticlePubMedGoogle Scholar
  7. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29:710–7.View ArticlePubMedGoogle Scholar
  8. Baker CD, Alvira CM. Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Curr Opin Pediatr. 2014;26:306–14.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.View ArticlePubMedGoogle Scholar
  10. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics. 2006;118:108–13.View ArticlePubMedGoogle Scholar
  11. Kotecha SJ, Edwards MO, Watkins WJ, Henderson AJ, Paranjothy S, Dunstan FD, et al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax. 2013;68:760–6.View ArticlePubMedGoogle Scholar
  12. Gibson AM, Reddington C, McBride L, Callanan C, Robertson C, Doyle LW. Lung function in adult survivors of very low birth weight, with and without Bronchopulmonary dysplasia. Pediatr Pulmonol. 2015;50:987–94.View ArticlePubMedGoogle Scholar
  13. Carraro S, Filippone M, Da Dalt L, Ferraro V, Maretti M, Bressan S, et al. Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev. 2013;89(Suppl 3):S3–5.View ArticlePubMedGoogle Scholar
  14. Vollsaeter M, Roksund OD, Eide GE, Markestad T, Halvorsen T. Lung function after preterm birth: development from mid-childhood to adulthood. Thorax. 2013;68:767–76.View ArticlePubMedGoogle Scholar
  15. Brostrom EB, Thunqvist P, Adenfelt G, Borling E, Katz-Salamon M. Obstructive lung disease in children with mild to severe BPD. Respir Med. 2010;104:362–70.View ArticlePubMedGoogle Scholar
  16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.View ArticlePubMedGoogle Scholar
  17. Thunqvist P, Gustafsson PM, Schultz ES, Bellander T, Berggren-Brostrom E, Norman M, et al. Lung function at 8 and 16 years after moderate-to-late preterm birth: a prospective cohort study. Pediatrics. 2016;137(4). doi:https://doi.org/10.1542/peds.2015-2056.
  18. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther. 2001;14:341–50.View ArticlePubMedGoogle Scholar
  19. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22:1026–41.View ArticlePubMedGoogle Scholar
  20. Al-Mutairi SS, Sharma PN, Al-Alawi A, Al-Deen JS. Impulse oscillometry: an alternative modality to the conventional pulmonary function test to categorise obstructive pulmonary disorders. Clin Exp Med. 2007;7:56–64.View ArticlePubMedGoogle Scholar
  21. Goldman MD, Saadeh C, Ross D. Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol. 2005;148:179–94.View ArticlePubMedGoogle Scholar
  22. Komarow HD, Myles IA, Uzzaman A, Metcalfe DD. Impulse oscillometry in the evaluation of diseases of the airways in children. Ann Allergy Asthma Immunol. 2011;106:191–9.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Nowowiejska B, Tomalak W, Radlinski J, Siergiejko G, Latawiec W, Kaczmarski M. Transient reference values for impulse oscillometry for children aged 3-18 years. Pediatr Pulmonol. 2008;43:1193–7.View ArticlePubMedGoogle Scholar
  24. Edwards MO, Kotecha SJ, Lowe J, Watkins WJ, Henderson AJ, Kotecha S. Effect of preterm birth on exercise capacity: a systematic review and meta-analysis. Pediatr Pulmonol. 2015;50:293–301.View ArticleGoogle Scholar
  25. Lovering AT, Elliott JE, Laurie SS, Beasley KM, Gust CE, Mangum TS, et al. Ventilatory and sensory responses in adult survivors of preterm birth and bronchopulmonary dysplasia with reduced exercise capacity. Ann Am Thorac Soc. 2014;11:1528–37.View ArticlePubMedGoogle Scholar
  26. Vrijlandt EJ, Gerritsen J, Boezen HM, Grevink RG, Duiverman EJ. Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med. 2006;173:890–6.View ArticlePubMedGoogle Scholar
  27. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87–90.View ArticlePubMedGoogle Scholar
  29. Bottai M, Frongillo EA, Sui X, O'Neill JR, McKeown RE, Burns TL, et al. Use of quantile regression to investigate the longitudinal association between physical activity and body mass index. Obesity (Silver Spring). 2014;22:E149–56.View ArticleGoogle Scholar
  30. Bottai M, Cai B, McKeown RE. Logistic quantile regression for bounded outcomes. Stat Med. 2010;29:309–17.PubMedGoogle Scholar
  31. Hallberg J, Thunqvist P, Schultz ES, Kull I, Bottai M, Merritt AS, et al. Asthma phenotypes and lung function up to 16 years of age-the BAMSE cohort. Allergy. 2015;70:667–73.View ArticlePubMedGoogle Scholar
  32. Halvorsen T, Skadberg BT, Eide GE, Roksund OD, Markestad T. Better care of immature infants; has it influenced long-term pulmonary outcome? Acta Paediatr. 2006;95:547–54.View ArticlePubMedGoogle Scholar
  33. Kotecha SJ, Watkins WJ, Paranjothy S, Dunstan FD, Henderson AJ, Kotecha S. Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents. Thorax. 2012;67:54–61.View ArticlePubMedGoogle Scholar
  34. Narang I, Rosenthal M, Cremonesini D, Silverman M, Bush A. Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med. 2008;178:74–80.View ArticlePubMedGoogle Scholar
  35. Filippone M, Sartor M, Zacchello F, Baraldi E. Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet. 2003;361:753–4.View ArticlePubMedGoogle Scholar
  36. Fortuna M, Carraro S, Temporin E, Berardi M, Zanconato S, Salvadori S, et al. Mid-childhood lung function in a cohort of children with “new bronchopulmonary dysplasia”. Pediatr Pulmonol. 2016;51:1057–64.View ArticlePubMedGoogle Scholar
  37. Malmberg LP, Mieskonen S, Pelkonen A, Kari A, Sovijarvi AR, Turpeinen M. Lung function measured by the oscillometric method in prematurely born children with chronic lung disease. Eur Respir J. 2000;16:598–603.View ArticlePubMedGoogle Scholar
  38. Vrijlandt EJ, Boezen HM, Gerritsen J, Stremmelaar EF, Duiverman EJ. Respiratory health in prematurely born preschool children with and without bronchopulmonary dysplasia. J Pediatr. 2007;150:256–61.View ArticlePubMedGoogle Scholar
  39. Clemm HH, Vollsaeter M, Roksund OD, Markestad T, Halvorsen T. Adolescents who were born extremely preterm demonstrate modest decreases in exercise capacity. Acta Paediatr. 2015;104:1174–81.View ArticlePubMedGoogle Scholar
  40. Silva DM, Nardiello C, Pozarska A, Morty RE. Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1239–72.PubMedGoogle Scholar
  41. Nardiello C, Mizikova I, Morty RE. Looking ahead: where to next for animal models of bronchopulmonary dysplasia? Cell Tissue Res. 2017;367:457–68.View ArticlePubMedGoogle Scholar
  42. Brew N, Hooper SB, Zahra V, Wallace M, Harding R. Mechanical ventilation injury and repair in extremely and very preterm lungs. PLoS One. 2013;8:e63905.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Kramer EL, Deutsch GH, Sartor MA, Hardie WD, Ikegami M, Korfhagen TR, et al. Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis. Am J Physiol Lung Cell Mol Physiol. 2007;293:L314–27.View ArticlePubMedGoogle Scholar
  44. Le Cras TD, Hardie WD, Deutsch GH, Albertine KH, Ikegami M, Whitsett JA, et al. Transient induction of TGF-alpha disrupts lung morphogenesis, causing pulmonary disease in adulthood. Am J Physiol Lung Cell Mol Physiol. 2004;287:L718–29.View ArticlePubMedGoogle Scholar
  45. Kotecha S, Wangoo A, Silverman M, Shaw RJ. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr. 1996;128:464–9.View ArticlePubMedGoogle Scholar
  46. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, Warburton D. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol. 2003;163:2575–84.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164:1971–80.View ArticlePubMedGoogle Scholar
  48. Backman H, Lindberg A, Sovijarvi A, Larsson K, Lundback B, Ronmark E. Evaluation of the global lung function initiative 2012 reference values for spirometry in a Swedish population sample. BMC Pulm Med. 2015;15:26.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement